Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hachinski, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hachinski, V.

(Stroke. 2001;32:2.)
© 2001 American Heart Association, Inc.


Editorials

Mark Dyken

A Tribute

Vladimir Hachinski, MD, DSc

From the University of Western Ontario, London, Ontario, Canada.

Correspondence to Dr Vladimir Hachinski, University of Western Ontario, 339 Windemere Rd, London, Ontario N6A 5A5, Canada. E-mail rebecca.nott@lhsc.on.ca


Key Words: editor • stroke

Few people achieve distinction in their careers. Dr Mark L. Dyken has excelled in many—clinician, teacher, investigator, leader, editor—all at a superb level.

Dr Dyken’s professional life began and continues as a masterful and compassionate clinician who loves teaching. Remarkably, 4 medical school classes at Indiana University voted him Outstanding Professor, and the university conferred upon him the Glen W. Irwin, Jr, MD Distinguished Faculty Award in 1994. Internationally, he has been honored by hundreds of visiting professorships, including 14 named lectureships and being named Professor Ad-Honorem at the University of Uruguay.

As an investigator, he led the first prospective controlled trial in stroke in the 1950s and the Cooperative Hospital Frequency Study of Transient Ischemic Attacks, the definitive study of the subject, in the 1970s. Since that time he has been involved in some capacity in every North American trial of antiplatelet drugs in stroke prevention and was one of the first to suggest that aspirin would also be effective in women.

As chairman of the Department of Neurology during 1971–1994, he put his department on the international map. His leadership also extended into other areas: President of the Association of University Professors of Neurology (1986–1988), the American Board of Psychiatry and Neurology (1995), and the Association for the Advancement of Mental Health Research and Education (1975–1996). He also has been a recognized leader within the American Heart Association, which conferred on him the Gold Heart Award, their highest honor, seldom bestowed on someone working in stroke. His peers . . . [Full Text of this Article]